Skip to main content
logo
Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
42.24
+1.24 (3.02%)
At close: Jan 22, 2026, 4:00 PM EST
42.02
-0.22 (-0.52%)
Pre-market: Jan 23, 2026, 7:26 AM EST

Xenon Pharmaceuticals Revenue

Xenon Pharmaceuticals had revenue of $7.50M in the twelve months ending September 30, 2025.

Revenue (ttm)
$7.50M
Revenue Growth
n/a
P/S Ratio
435.21
Revenue / Employee
$22,936
Employees
327
Market Cap
3.26B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 20229.43M-9.00M-48.83%
Dec 31, 202118.44M-13.73M-42.68%
Dec 31, 202032.17M25.34M371.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Catalyst Pharmaceuticals578.20M
Tarsus Pharmaceuticals366.10M
Arcutis Biotherapeutics317.93M
IDEAYA Biosciences214.83M
Viridian Therapeutics70.79M
Liquidia69.22M
Beam Therapeutics55.70M
Centessa Pharmaceuticals15.00M
Revenue Rankings

XENE News

More News